Results 181 to 190 of about 179,968 (219)

Active Surveillance for Small Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis

Thyroid, 2019
Background: The rapid increase in the incidence of small papillary thyroid carcinoma (PTC) appears to be caused by the detection of small thyroid cancers. Active surveillance (AS) was therefore suggested to overcome this problem.
Se Jin Cho, C. Suh, J. Baek, Sae Rom Chung, Y. Choi, K. Chung, Y. Shong, Jeong Hyun Lee   +7 more
semanticscholar   +1 more source

Role of matrix metalloproteinases and their inhibitors in the development of cervical metastases in papillary thyroid cancer

Clinical Otolaryngology, 2020
To investigate the role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of cervical metastases in papillary thyroid cancer.
Boris Bumber, M. Marjanović Kavanagh, A. Jakovčević, N. Sinčić, R. Prstačić, D. Prgomet   +5 more
semanticscholar   +1 more source

Thyroid Cancer: A Review.

Journal of the American Medical Association (JAMA)
Importance Approximately 43 720 new cases of thyroid carcinoma are expected to be diagnosed in 2023 in the US. Five-year relative survival is approximately 98.5%.
Laura Boucai, M. Zafereo, M. Cabanillas
semanticscholar   +1 more source

MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression

Thyroid, 2018
Background: Increasing evidence indicates that microRNA dysfunction is involved in the pathogenesis and progression of cancer. MicroRNA-222 (miR-222) is upregulated in papillary thyroid carcinoma (PTC).
Yanrui Huang, Shuang Yu, Siting Cao, Yali Yin, Shubin Hong, H. Guan, Yanbing Li, Haipeng Xiao   +7 more
semanticscholar   +1 more source

Long non‐coding RNA TTN‐AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR‐153‐3p/ZNRF2 axis

Journal of Gene Medicine, 2019
Long non‐coding RNAs (lncRNAs) are crucial modulators in the tumorigenesis of numerous cancers, including papillary thyroid cancer (PTC). However, it is unclear whether lncRNA TTN antisense RNA 1 (TTN‐AS1) can regulate PTC progression.
Z. Cui, Zhiyan Luo, Zimei Lin, Liuhong Shi, Yu-rong Hong, Caoxin Yan   +5 more
semanticscholar   +1 more source

Clinicopathological predictors of occult lateral neck lymph node metastasis in papillary thyroid cancer: A meta‐analysis

Head and Neck, 2019
This meta‐analysis aimed to identify the clinicopathological factors that could predict the risk of occult lateral neck lymph node metastasis (OLLNM) in N0/N1a papillary thyroid cancer (PTC).
Shaohua Zhan, Dan Luo, Wei Ge, Bin Zhang, Tian-xiao Wang   +4 more
semanticscholar   +1 more source